Hong Jang Hee, Jin Eun-Heui, Chang In Ae, Kang Hyojin, Lee Sang-Il, Sung Jae Kyu
Clinical Trials Center, Chungnam National University Hospital, Daejeon, Republic of Korea.
Department of Pharmacology, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
Pharmgenomics Pers Med. 2020 Apr 9;13:121-126. doi: 10.2147/PGPM.S247082. eCollection 2020.
Gastric cancer (GC) is one of the most common cancers in the world. Recently, several studies have suggested that single-nucleotide polymorphisms (SNPs) of long noncoding RNA (lncRNA) are associated with GC risk. However, the association of the lncRNA highly upregulated in liver cancer () SNP with GC risk is not yet known. The aims of this study were to evaluate the association between rs7763881 SNP and the risk of GC and GC subgroups via a case-control study.
rs7763881 was genotyped using TaqMan genotyping assay with 459 GC patients and 379 controls.
A significant association between rs7763881 SNP and GC risk was not found. However, after adjustment for age and gender, the rs7763881 recessive model (CC) showed a significant association with an increased GC risk in the undifferentiated (odds ratio (OR) = 1.85, 95% confidence interval (CI) = 1.17-2.94, = 0.009), diffuse-type GC (OR = 1.72, 95% CI = 1.05-2.82, = 0.033), LNM-positive (OR = 2.02, 95% CI = 1.24-3.27, = 0.004), T3/T4 (OR = 1.75, 95% CI = 1.05-2.91, = 0.032), and tumor stage III (OR = 2.01, 95% CI = 1.17-3.45, = 0.011) subgroups when compared to the rs7763881 combined genotypes (AA+AC). Furthermore, after adjusting for age and gender, the rs7763881 additive model (CC) indicated a significantly higher GC risk than rs7763881 AA genotype in the undifferentiated (OR = 1.96, 95% CI = 1.15-3.32, = 0.013), diffuse-type GC (OR = 2.08, 95% CI = 1.23-3.52, = 0.004), and LNM-positive (OR = 2.00, 95% CI = 1.14-3.49, = 0.016) subgroups.
Our findings suggest that the rs7763881 SNP is associated with increased susceptibility to GC. However, further studies are required to validate our results in large populations as well as different ethnic groups.
胃癌(GC)是世界上最常见的癌症之一。最近,几项研究表明,长链非编码RNA(lncRNA)的单核苷酸多态性(SNP)与胃癌风险相关。然而,肝癌中高度上调的lncRNA()SNP与胃癌风险的关联尚不清楚。本研究的目的是通过病例对照研究评估rs7763881 SNP与胃癌及胃癌亚组风险之间的关联。
采用TaqMan基因分型检测法对459例胃癌患者和379例对照进行rs7763881基因分型。
未发现rs7763881 SNP与胃癌风险之间存在显著关联。然而,在调整年龄和性别后,rs7763881隐性模型(CC)显示与未分化型胃癌(优势比(OR)=1.85,95%置信区间(CI)=1.17 - 2.94,=0.009)、弥漫型胃癌(OR = 1.72,95% CI = 1.05 - 2.82,=0.033)、淋巴结转移阳性(OR = 2.02,95% CI = 1.24 - 3.27,=0.004)、T3/T4期(OR = 1.75,95% CI = 1.05 - 2.91,=0.032)和肿瘤III期(OR = 2.01,95% CI = 1.17 - 3.45,=0.011)亚组的胃癌风险增加显著相关,与rs7763881联合基因型(AA + AC)相比。此外,在调整年龄和性别后,rs7763881加性模型(CC)在未分化型胃癌(OR = 1.96,95% CI = 1.15 - 3.32,=0.013)、弥漫型胃癌(OR = 2.08,95% CI = 1.23 - 3.52,=0.004)和淋巴结转移阳性(OR = 2.00,95% CI = 1.14 - 3.49,=0.016)亚组中显示出比rs7763881 AA基因型显著更高的胃癌风险。
我们的研究结果表明,rs7763881 SNP与胃癌易感性增加有关。然而,需要进一步的研究在大量人群以及不同种族群体中验证我们的结果。